SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 54 filers reported holding SAVARA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 142 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 142 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 4,980,804 | $16,026,005 | 46.25% |
| NEA Management Company, LLC | 24,137,931 | $77,120,690 | 5.89% |
| Bain Capital Life Sciences Investors, LLC | 11,622,598 | $37,134,201 | 3.82% |
| VR Adviser, LLC | 6,351,531 | $20,293,142 | 3.24% |
| Sio Capital Management, LLC | 1,010,701 | $3,229,190 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 198,139 | $633,054 | 0.43% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,908,086 | $34,851,335 | 0.18% |
| Parkman Healthcare Partners LLC | 206,607 | $660,109 | 0.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,064,551 | $19,376,240 | 0.04% |
| ClariVest Asset Management LLC | 242,900 | $776 | 0.04% |